Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00095225
Status:
COMPLETED
Last Update Posted:
2008-01-29
First Post:
2004-11-01
Brief Title:
A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC Non-Small Cell Lung Cancer
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasm Recurrence Local |
| Non-Small-Cell Lung Carcinoma |
Keywords:
| Name | View |
|---|---|
| Recurrent or refractory non-small cell lung cancer | View |